175 related articles for article (PubMed ID: 7521432)
1. [Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy].
Kaji K; Unoura M; Kobayashi K; Nakanuma Y
Nihon Rinsho; 1994 Jul; 52(7):1865-8. PubMed ID: 7521432
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological studies of anti-HCV P1P4 core antibody].
Shibuya A; Asano A; Tsuchihashi T; Sakurai K; Takeuchi A; Shibata H
Rinsho Byori; 1995 Mar; 43(3):285-9. PubMed ID: 7538180
[TBL] [Abstract][Full Text] [Related]
4. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
Nagayama R; Shoji S; Miyake K
Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune hepatitis and viral infection.
Czaja AJ
Gastroenterol Clin North Am; 1994 Sep; 23(3):547-66. PubMed ID: 7527373
[TBL] [Abstract][Full Text] [Related]
6. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C antibody and HCV-RNA].
Yano M
Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):192-6. PubMed ID: 7525797
[No Abstract] [Full Text] [Related]
8. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
Hige S
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
[TBL] [Abstract][Full Text] [Related]
9. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
Thiele DL; DuCharme L; Cunningham MR; Mimms LT; Cuthbert JA; Lee WM; Combes B
Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C.
Sherlock DS
Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
[TBL] [Abstract][Full Text] [Related]
11. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
12. [The clinical usefulness of a new (the second generation) antibody to hepatitis C virus].
Kiyosawa K; Tanaka E; Sodeyama T; Furuta S; Kameko M; Katsuyama T
Rinsho Byori; 1992 Dec; 40(12):1245-51. PubMed ID: 1284913
[TBL] [Abstract][Full Text] [Related]
13. [Histological assessment of the liver long after interferon treatment in patients with chronic type C hepatitis].
Yokosuka O; Hosoda K; Omata M
Nihon Rinsho; 1994 Jul; 52(7):1841-6. PubMed ID: 7521428
[TBL] [Abstract][Full Text] [Related]
14. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.
Alter MJ; Margolis HS; Krawczynski K; Judson FN; Mares A; Alexander WJ; Hu PY; Miller JK; Gerber MA; Sampliner RE
N Engl J Med; 1992 Dec; 327(27):1899-905. PubMed ID: 1280771
[TBL] [Abstract][Full Text] [Related]
15. [Summary and evaluation of genome and antibody diagnosis in hepatitis C virus infection].
Nishizono A
Rinsho Byori; 1994 Dec; 42(12):1240-7. PubMed ID: 7532727
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of determination of anti-HCV antibodies].
Takase K; Tameda Y; Kosaka Y
Rinsho Byori; 1994 Oct; 42(10):1003-9. PubMed ID: 7527869
[TBL] [Abstract][Full Text] [Related]
17. [Interferon therapy for acute hepatitis C; changes in serum markers associated with HCV and clinical effects].
Fukui S; Tohyama H; Iwabuchi S
Nihon Rinsho; 1994 Jul; 52(7):1847-51. PubMed ID: 7521429
[TBL] [Abstract][Full Text] [Related]
18. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
19. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
[TBL] [Abstract][Full Text] [Related]
20. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
